Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bon Natural Life (BON) Cash & Equivalents (2020 - 2025)

Bon Natural Life (BON) has disclosed Cash & Equivalents for 5 consecutive years, with $80466.0 as the latest value for Q3 2024.

  • On a quarterly basis, Cash & Equivalents rose 5204.28% to $80466.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $80466.0, a 5204.28% increase, with the full-year FY2024 number at $80466.0, up 5204.28% from a year prior.
  • Cash & Equivalents was $80466.0 for Q3 2024 at Bon Natural Life, up from $1517.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.9 million in Q3 2021 to a low of $1517.0 in Q3 2023.
  • A 5-year average of $575963.4 and a median of $80466.0 in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 99.82% in 2023, then skyrocketed 5204.28% in 2024.
  • Bon Natural Life's Cash & Equivalents stood at $53106.0 in 2020, then surged by 3485.03% to $1.9 million in 2021, then crashed by 55.83% to $840861.0 in 2022, then plummeted by 99.82% to $1517.0 in 2023, then surged by 5204.28% to $80466.0 in 2024.
  • Per Business Quant, the three most recent readings for BON's Cash & Equivalents are $80466.0 (Q3 2024), $1517.0 (Q3 2023), and $840861.0 (Q3 2022).